Note: Ingredients listed on restricted chemical lists
EC/CAS
207-838-8/497-19-8
Name of the chemical
Sodium carbonate
Concentration
≥35-<50
EC/CAS
225-768-6/5064-31-3
Name of the chemical
Trisodium nitrilotriacetate
Concentration
<5
General Information
Version
1.01
Revision date
2018-01-22
Product name
HG silver immersion bath
supplier name
HG Hagesan UK Ltd
Emergency telephone
0044 (0)1206 827019, 0845 4647, 01 809 2166, +31 (0)36 54 94 777
Icons in SDS
Company Information
company name
HG Hagesan UK Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@hg.eu, safety@hg.eu
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
Causes serious eye irritation.
Precautionary statements
General If medical advice is needed: Have product container or label at hand. Keep out of reach of children.
Prevention
Wash hands thoroughly after handling.
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage
Not applicable
Disposal
Not applicable
Supplemental label elements
Contact with acids liberates toxic gas. elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Eye Irrit. 2, H319 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
